PARIS (Reuters) – France will take a stake in Sanofi (NASDAQ:)’s Opella by way of the Public Funding Financial institution (BPI), finance minister Antoine Armand mentioned on Sunday, confirming an data from Le Figaro newspaper that U.S. personal fairness agency Clayton Dubilier & Rice (CD&R) is to take a 51% stake within the firm that makes of certainly one of France’s most-sold painkillers, Doliprane.
The plan for Public Funding Financial institution (BPI) to take a 1% stake in Opella, for about 150 million euros ($162.98 million), got here by way of a tri-party settlement between Sanofi, the French state and CD&R and was accepted by Sanofi’s board on Sunday, the newspaper mentioned.
Finance minister Antoine Armand had mentioned earlier this week that the federal government was all choices relating to Opella, together with the state being on Opella’s board of administrators.
($1 = 0.9204 euros)
